Joseph Romanelli - 26 Jan 2026 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, Human Health Int?l
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Issuer symbol
MRK
Transactions as of
26 Jan 2026
Net transactions value
+$612,502
Form type
4
Filing time
28 Jan 2026, 16:14:43 UTC
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Romanelli Joseph President, Human Health Int?l MERCK & CO., INC., 126 EAST LINCOLN AVENUE, RAHWAY /s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli 28 Jan 2026 0001938322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $612,502 +5,703 +25% $107.40 28,739 26 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/23. Performance shares were paid out at 94 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2025.
F2 Holdings include shares acquired in dividend reinvestment transactions.